First result of differentiated communication—to smokers and non-smokers—in order to increase the voluntary participation rate in lung screening

BMC Public Health

Imre Repa²  János Strausz¹  Marianna Rakvács¹  Zsuzsanna Lelovics²  Gábor Bajzik²  Mariann Moizs¹ 

[1] “Moritz Kaposi” General Hospital, Kaposvár, Hungary;Institute of Diagnostic Imaging and Radiation Oncology, Health Center, Kaposvár University, Kaposvár, Hungary

关键词: Communication strategy;    Smoking;    Lung cancer;    Lung screening;   

Others  :  1161708
DOI  :  10.1186/1471-2458-13-914

 received in 2013-03-20, accepted in 2013-09-25,  发布年份 2013

【 摘 要 】

Background

Lung cancer is the most common fatal malignacy and also the primary cause of cancer mortality. Participation in lung screening is an important step in diagnosing patient in early stage and it can promise better outcomes. The aim of this preliminary study was to determinate the differences in the participation rate of smokers and non-smokers in lung cancer screening and to determine the communication strategies to increase the participation rate.

Methods

In the given period of time (from May to August 2012) out of 1426 people who participated in the lung screening program 1,060 adult volunteers (331 males and 729 females, average age 54.0±9.3 years), completed fully and anonymously author’s questionnaire that contained 28 questions. 25.7% of the respondents were smokers (n=272), 64.6% have never smoked, while 9.7% were former smokers.

Results

Mostly former smokers considered lung screening as an effective method for early detection of pulmonary diseases (86.4%). The most important source (41.0%) of information was the general practitioner. The participation rate of non-smokers is higher in lung screening than the ratio of non-smokers in the population. The unclear data suggest that smokers need distinct, concise messages to know why they should regularly undergo lung screening and doctors have a major role in this.

Conclusions

We found that smokers significantly more frequently took part in lung screening annually. It is positive that the participation rate of former smokers is higher than non-smokers, it is just a bit lower than the participation rate of smokers—both in annual and biannual participation. The participation rate of non-smokers is higher in lung screening than the rate of non-smokers in the population.

【 授权许可】

   
2013 Moizs et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

Figure 11.

【 参考文献 】

• [1]Youlden DR, Cramb SM, Baade PD: The international epidemiology of lung cancer: geographical distribution and secular trends. J Thorac Oncol 2008, 3:819-831.
• [2]KSH: [Pulmonary diseases]. Stat Tükör 2009, 3:1-3. [In Hung.]
• [3]Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ: The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012, 144:33-38.
• [4]Fact Sheet – IARC 2008. Retrieved January 16, 2012 from http://globocan.iarc.fr/ webcite (Select a cancer: Lung)
• [5]WHO Media Center: Cancer Fact Sheet. No. 297. 2012. Retrieved December 3, 2012 from http://www.who.int/mediacentre/factsheets/fs297/en/ webcite
• [6]Didkowska J, Manczuk M, McNeill A, Powles J, Zatonski W: Lung cancer mortality at ages 35-54 in the European Union: ecological study of evolving tobacco epidemics. BMJ 2005, 331:189-192.
• [7]Dela Cruz CS, Tanoue LT, Matthay RA: Lung Cancer: epidemiology, etiology and prevention. Clin Chest Med 2011, 32:605-644.
• [8]Torok S, Hegedus B, Laszlo V, Hoda MA, Ghanim B, Berger W, Klepetko W, Dome B, Ostoros G: Lung cancer in never smokers. Future Oncol 2011, 7:1195-1211.
• [9]Lung cancer mortality statistics. 2012. Retrieved November 7, 2012 from http://www.cancerresearchuk.org/cancer-info/cancerstats/types/lung/mortality/uk-lung-cancer-mortality-statistics webcite
• [10]Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC: Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012, 307:2418-2429.
• [11]McLoud TC: Initial results of the National Lung Cancer Screening Trial. Cancer Imaging 2011, 11:S85.
• [12]Rampinelli C, Preda L, Maniglio M, Sirica L, Travaini LL, Veronesi G, Bellomi M: Extrapulmonary malignancies detected at lung cancer screening. Radiology 2011, 261:293-299.
• [13]Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C: Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012, 21:308-315.
• [14]Brennan P, Crispo A, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Fabiánová E, Mates D, Bencko V, Foretova L, Janout V, Fletcher T, Boffetta P: High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. Am J Epidemiol 2006, 164:1233-1241.
• [15]Zafar Y, Kleykamp B, Foraida M, Neu J, Buncher R, Shipley R, Howington J: Characteristics and motivations of participants in a lung cancer screening study. J Clin Oncol 2004, 22:1032. Retrived from http://meeting.ascopubs.org/cgi/content/abstract/22/14_suppl/1032 webcite
• [16]Wood DA, Kinmonth AL, Davies GA, Yarwood J, Thompson SG, Pyke SDM, Kok Y, Cramb R, Le Guena C, Marteaua TM, Durrington PN: Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study. BMJ 1994, 308:313-320.
• [17]OXOCHECH Study Group: Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. Imperial Cancer Research Fund OXCHECK Study Group. BMJ 1995, 310:1099-1104.
• [18]Deutekom M, Vansenne F, McCaffery K, Essink-Bot M, Stronks K, Bossuyt PMM: The effects of screening on health behaviour: a summary of the results of randomized controlled trials. J Public Health 2010, 33:71-79.
• [19]Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF, National Lung Screening Trial Research Team: Baseline characteristics of participants in the randomized National Lung Screening Trial. J Natl Canc Inst 2010, 102:1771-1779.